ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary ...
Anaergia Inc. has appointed long-time executive Sasha Rollings-Scattergood as Chief Technology Officer, effective January 1, ...
Q4 2025 earnings call highlights: record revenue/EPS, Wealth margin gains, IB rebound, and 2026 NII outlook—read key ...
The slow start to the political year is well and truly over. Westminster can stop pretending to worry about Greenland, ...
NMC Healthcare will be “sold” eventually, but shareholders are not looking at the exit strategy now, said its chief executive ...
The Blazpay AI crypto presale has hit a milestone, which is a great moment for the project as it has already collected $2.29 ...
Yogi Adityanath applied the same principle to Uttar Pradesh. The state would no longer chase announcements, subsidies alone, ...
Rollins (ROL) 2025: 12% revenue growth and margin gains, but valuation >50x earnings with ~2% FCF yield. Click here to read ...
Unpack the Texans' thrilling Wild Card triumph and get a strategic preview of Sunday's pivotal Divisional Round clash against ...
Fund IV will continue the successful strategy of its predecessor funds, targeting investments in undermanaged European lower middle market companies where H.I.G. can apply its operational ...
This is the first in a five-part series about railroad growth coming from truck conversions. Given Union Pacific’s proposed ...
Q4 2025 Management View John Allison, Co-Founder, Chairman & CEO, opened by highlighting, “For the full year of 2025, the ...